Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
15.72
-0.45 (-2.78%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
388,521
Open
16.23
Bid (Size)
15.72 (100)
Ask (Size)
17.00 (100)
Prev. Close
16.17
Today's Range
15.58 - 16.30
52wk Range
10.45 - 18.91
Shares Outstanding
353,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Billboard Giant Posts $1.6 Billion Revenue as $20.5 Million Bet Makes It a Top Portfolio Holding
↗
March 12, 2026
This outdoor advertising firm operates a vast network of displays across the Americas and Europe, serving a diverse global client base.
Via
The Motley Fool
Topics
Regulatory Compliance
Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position
↗
March 12, 2026
Bausch + Lomb provides eye health products and surgical devices globally, serving both healthcare professionals and consumers.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-5.2%
-5.2%
1 Month
-10.9%
-10.9%
3 Month
-7.1%
-7.1%
6 Month
+3.1%
+3.1%
1 Year
+1.0%
+1.0%
More News
Read More
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
March 09, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Corp (NYSE:BLCO) Reports Mixed Q4 2025 Results: Revenue Beat, EPS Miss
↗
February 18, 2026
Via
Chartmill
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know
March 06, 2026
Via
StockStory
Topics
Earnings
Economy
2 Profitable Stocks Worth Investigating and 1 We Ignore
March 04, 2026
Via
StockStory
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
March 03, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Retirement
5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call
February 25, 2026
Via
StockStory
Topics
Earnings
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
February 24, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
3 Small-Cap Stocks We Steer Clear Of
February 22, 2026
Via
StockStory
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus
February 19, 2026
Via
StockStory
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue
February 18, 2026
Via
StockStory
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
February 18, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb (BLCO) Q4 Earnings: What To Expect
February 16, 2026
Via
StockStory
Topics
World Trade
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
February 09, 2026
Via
StockStory
Topics
Bankruptcy
Stocks
1 Healthcare Stock to Research Further and 2 Facing Headwinds
January 29, 2026
Via
StockStory
Topics
Stocks
3 Stocks Under $50 That Fall Short
January 26, 2026
Via
StockStory
3 Cash-Burning Stocks We’re Skeptical Of
January 22, 2026
Via
StockStory
Topics
Bankruptcy
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
January 20, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
January 05, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
January 02, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
1 Profitable Stock to Keep an Eye On and 2 We Question
December 17, 2025
Via
StockStory
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
↗
December 17, 2025
Via
The Motley Fool
Bausch + Lomb Announces Two Board of Directors Appointments
December 17, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Frequently Asked Questions
Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 15.72
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 03/20/26 07:00 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.56B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.